Cardiac surgery and neuromodulation device company LivaNova’s former CEO Damien McDonaldresigned in April, with board chair William Kozy still handling interim CEO responsibilities as of the writing of this description in early August. Mike Matson, senior research analyst at Needham & Co., noted that McDonald’s departure came after several pipeline disappointments.–CN